4/18
02:03 am
biol
BIOLASE, Inc. (NASDAQ: BIOL) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
BIOLASE, Inc. (NASDAQ: BIOL) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
4/16
05:37 pm
biol
Global Dental Lasers Market to Witness Upsurge in Growth at a CAGR of ~5% by 2030 | DelveInsight [Yahoo! Finance]
Medium
Report
Global Dental Lasers Market to Witness Upsurge in Growth at a CAGR of ~5% by 2030 | DelveInsight [Yahoo! Finance]
4/10
02:02 am
biol
BIOLASE, Inc. (NASDAQ: BIOL) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
BIOLASE, Inc. (NASDAQ: BIOL) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
4/2
02:05 am
biol
BIOLASE, Inc. (NASDAQ: BIOL) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
BIOLASE, Inc. (NASDAQ: BIOL) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
3/25
02:06 am
biol
BIOLASE, Inc. (NASDAQ: BIOL) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
BIOLASE, Inc. (NASDAQ: BIOL) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
3/23
10:00 am
biol
BIOLASE, Inc. (NASDAQ:BIOL) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Low
Report
BIOLASE, Inc. (NASDAQ:BIOL) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
3/22
01:46 pm
biol
BIOLASE, Inc. (NASDAQ: BIOL) had its price target lowered by analysts at Benchmark Co. from $2.50 to $0.40. They now have a "speculative buy" rating on the stock.
Medium
Report
BIOLASE, Inc. (NASDAQ: BIOL) had its price target lowered by analysts at Benchmark Co. from $2.50 to $0.40. They now have a "speculative buy" rating on the stock.
3/22
09:31 am
biol
Thinking about buying stock in Xpeng, Ocugen, Quantum Computing, CONSERVATIVE BROADCAST MEDIA JOURNALISM, or BIOLASE?
High
Report
Thinking about buying stock in Xpeng, Ocugen, Quantum Computing, CONSERVATIVE BROADCAST MEDIA JOURNALISM, or BIOLASE?
3/21
04:29 pm
biol
Biolase GAAP EPS of -$1.76 beats by $0.80, revenue of $13.49M beats by $0.27M [Seeking Alpha]
Medium
Report
Biolase GAAP EPS of -$1.76 beats by $0.80, revenue of $13.49M beats by $0.27M [Seeking Alpha]
3/21
04:14 pm
biol
Biolase Reports Full-Year 2023 Results; Expects Continued Revenue Growth In 2024 [Yahoo! Finance]
High
Report
Biolase Reports Full-Year 2023 Results; Expects Continued Revenue Growth In 2024 [Yahoo! Finance]
3/21
04:05 pm
biol
Biolase Reports Full-Year 2023 Results; Expects Continued Revenue Growth In 2024
High
Report
Biolase Reports Full-Year 2023 Results; Expects Continued Revenue Growth In 2024
3/17
02:02 am
biol
BIOLASE, Inc. (NASDAQ: BIOL) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
BIOLASE, Inc. (NASDAQ: BIOL) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
3/14
06:51 am
biol
BIOLASE to Report Fourth Quarter and Full Year 2023 Results on March 21, 2024 [Yahoo! Finance]
Low
Report
BIOLASE to Report Fourth Quarter and Full Year 2023 Results on March 21, 2024 [Yahoo! Finance]
3/14
06:30 am
biol
BIOLASE to Report Fourth Quarter and Full Year 2023 Results on March 21, 2024
Low
Report
BIOLASE to Report Fourth Quarter and Full Year 2023 Results on March 21, 2024
3/9
02:08 am
biol
BIOLASE, Inc. (NASDAQ: BIOL) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
BIOLASE, Inc. (NASDAQ: BIOL) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
3/1
02:04 am
biol
BIOLASE, Inc. (NASDAQ: BIOL) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
High
Report
BIOLASE, Inc. (NASDAQ: BIOL) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
2/22
06:41 am
biol
Biolase Launches State-of-the-Art All-Tissue Laser System To Accelerate Adoption of Lasers in Dentistry [Yahoo! Finance]
Low
Report
Biolase Launches State-of-the-Art All-Tissue Laser System To Accelerate Adoption of Lasers in Dentistry [Yahoo! Finance]
2/22
06:30 am
biol
Biolase Launches State-of-the-Art All-Tissue Laser System To Accelerate Adoption of Lasers in Dentistry
Medium
Report
Biolase Launches State-of-the-Art All-Tissue Laser System To Accelerate Adoption of Lasers in Dentistry
2/22
02:03 am
biol
BIOLASE, Inc. (NASDAQ: BIOL) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
BIOLASE, Inc. (NASDAQ: BIOL) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
2/20
06:42 am
biol
Biolase Announces First Quarter 2024 Webinar Series 'Lets Talk Dental' [Yahoo! Finance]
Medium
Report
Biolase Announces First Quarter 2024 Webinar Series 'Lets Talk Dental' [Yahoo! Finance]
2/20
06:30 am
biol
Biolase Announces First Quarter 2024 Webinar Series 'Lets Talk Dental'
Low
Report
Biolase Announces First Quarter 2024 Webinar Series 'Lets Talk Dental'
2/15
02:45 pm
biol
BIOLASE, Inc. Announces Closing of $7.0 Million Public Offering
Low
Report
BIOLASE, Inc. Announces Closing of $7.0 Million Public Offering
2/14
12:05 pm
biol
Dental Lasers Market Forecast to 2033 - Segments, Share, Regulatory, Reimbursement and Installed Base [Yahoo! Finance]
Low
Report
Dental Lasers Market Forecast to 2033 - Segments, Share, Regulatory, Reimbursement and Installed Base [Yahoo! Finance]
2/14
06:40 am
biol
BIOLASE, Inc. Granted Extension by Nasdaq to Regain Compliance with the Stockholders' Equity Continued Listing Requirement [Yahoo! Finance]
High
Report
BIOLASE, Inc. Granted Extension by Nasdaq to Regain Compliance with the Stockholders' Equity Continued Listing Requirement [Yahoo! Finance]
2/14
06:30 am
biol
BIOLASE, Inc. Granted Extension by Nasdaq to Regain Compliance with the Stockholders' Equity Continued Listing Requirement
Medium
Report
BIOLASE, Inc. Granted Extension by Nasdaq to Regain Compliance with the Stockholders' Equity Continued Listing Requirement